Switching to the Dry-Powder Inhaler Easyhaler®: A Narrative Review of the Evidence
Autor: | Lilla Tamási, Mária Szilasi, Jörgen Syk, Athanasios Xanthopoulos, Tari Haahtela, Paula Rytilä, Federico Lavorini, Anna S. Pelkonen, Abel Pallarés-Sanmartin, Jerzy Chudek, Gabriella Gálffy |
---|---|
Rok vydání: | 2021 |
Předmět: |
Pulmonary and Respiratory Medicine
030213 general clinical medicine medicine.medical_specialty Patient-centered outcomes Respiratory Medicine and Allergy Pressurized metered-dose inhaler 03 medical and health sciences 0302 clinical medicine Respiratory Care Dry-powder inhaler medicine COPD Respiratory function Intensive care medicine Lungmedicin och allergi Asthma business.industry Inhaler medicine.disease 3. Good health Easyhaler 030228 respiratory system Adherence 13. Climate action Salbutamol business Compliance Patient education medicine.drug |
Zdroj: | Pulmonary Therapy. 7:409-427 |
ISSN: | 2364-1746 2364-1754 |
DOI: | 10.1007/s41030-021-00174-5 |
Popis: | Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a substantial contributing factor to the suboptimal clinical control of both conditions. The practicality, dependability, and acceptability of different inhalers influence the overall effectiveness and success of inhalation therapy. In this paper, experts from various European countries (Finland, Germany, Hungary, Italy, Poland, Spain, and Sweden) address inhaler selection with special focus on the Easyhaler® device, a high- or medium-high resistance dry-powder inhaler (DPI). The evidence examined indicates that use of the Easyhaler is associated with effective control of asthma or COPD, as shown by the generally accepted indicators of treatment success. Moreover, the Easyhaler is widely accepted by patients, is reported to be easy to learn and teach, and is associated with patient adherence. These advantages help patient education regarding correct inhaler use and the rational selection of drugs and devices. We conclude that switching inhaler device to the Easyhaler may improve asthma and COPD control without causing any additional risks. In an era of climate change, switching from pressurized metered-dose inhalers to DPIs is also a cost-effective way to reduce emissions of greenhouse gases. Enhanced feature (slides, video, animation) (MP4 43768 kb). |
Databáze: | OpenAIRE |
Externí odkaz: |